XTX Topco’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
XTX Topco's XBI Position: Q1 2026 in Review
XTX Topco sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 3,794 shares — an estimated $463K sold.
XTX Topco first reported a position in XBI in Q2 2025 and held it in 3 quarters. The position peaked at $5.84M in Q2 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- XTX Topco reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
- XTX Topco sold 3,794 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $463K.
- XTX Topco first reported a position in State Street SPDR S&P Biotech ETF in Q2 2025 and held it in 3 quarters.
- XTX Topco's State Street SPDR S&P Biotech ETF position peaked at $5.84M in Q2 2025.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.